Rapid Review
| Assessment Status | Assessment process complete | |
| Rapid review commissioned | 09/08/2013 | |
| Rapid review completed | 17/09/2013 | |
| Rapid Review Outcome | Full Pharmacoeconomic Evaluation not recommended | |
| A new application for reimbursement was made to the HSE and a rapid review was commissioned in November 2017. | ||
| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Modified Release Hydrocortisone |
| Brand | Plenadren® |
| Indication | For the treatment of adrenal insufficiency in adults. |
| Assessment Process | |
| Rapid review commissioned | 08/11/2017 |
| Rapid review completed | 11/01/2018 |
| Rapid review outcome | Reimbursement not recommended at the submitted price. |
